Sign inJoin waitlistJoin the waitlist

JM

James Mier

Hematology and Oncology Research Investigator · Beth Israel Deaconess Medical Center

Credentials: · ·

History

Beth Israel Deaconess Medical Center
Present

Medical Oncology
1976–1978
Internal Medicine
1973–1976
Indiana University School of Medicine
1969–1973

Research

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion
Cancer Research · 2005 · 675 citations
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
Blood · 1994 · Last of 5 authors · 670 citations
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology · 2005 · 628 citations

Michael Atkins
81 papers · 2 as a fellow
Jeffrey Sosman
19 papers
David McDermott
18 papers · 1 as a fellow
Kim Margolin
17 papers
Sabina Signoretti
15 papers · 5 as a fellow
GW
Geoffrey Weiss
14 papers
FA
Frederick Aronson
12 papers · 1 as a fellow
RF
Richard Fisher
11 papers
ET
Elizabeth Trehu
9 papers
RB
Rupal Bhatt
9 papers
DC
Daniel Cho
8 papers · 1 as a fellow
Joseph Clark
7 papers

Grants

DF/HCC Kidney Cancer SPORE
National Cancer Institute · P50
Project lead · $1.5M · Beth Israel Deaconess Medical Center
2009–2015
SPORE in Skin Cancer
National Cancer Institute · P50
Project lead · $1.5M · Brigham and Women's Hospital
2008–2014
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $57.7K · Beth Israel Deaconess Medical Center
2005–2007
Clinical Trials with IL12
National Cancer Institute · R21
Contact PI · $306K · Beth Israel Deaconess Medical Center
2001–2003